29Paust S, Blish CA, Reeves RK: Redefining memory: building the case for adaptive NK cells. J Virol 2017;91:pii:e00169-17.
30Sun JC, Ugolini S, Vivier E: Immunological memory within the innate immune system. EMBO J 2014;33:1295–1303.
31Cooper MA, Fehniger TA, Caligiuri MA: The biology of human natural killer-cell subsets. Trends Immunol 2001;22:633–640.
32Montaldo E, Del Zotto G, Della Chiesa M, Mingari MC, Moretta A, De Maria A, Moretta L: Human NK cell receptors/markers: a tool to analyze NK cell development, subsets and function. Cytometry A 2013;83:702–713.
33Freud AG, Mundy-Bosse BL, Yu J, Caligiuri MA: The broad spectrum of human natural killer cell diversity. Immunity 2017;47:820–833.
34Freud AG, Yu J, Caligiuri MA: Human natural killer cell development in secondary lymphoid tissues. Semin Immunol 2014;26:132–137.
35Knox JJ, Cosma GL, Betts MR, McLane LM: Characterization of T-bet and eomes in peripheral human immune cells. Front Immunol 2014;5:217.
36Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S: Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol 2013;31:227–258.
37Le Page A, Bourgade K, Lamoureux J, Frost E, Pawelec G, Larbi A, Witkowski JM, Dupuis G, Fülöp T: NK Cells are activated in amnestic mild cognitive impairment but not in mild Alzheimer’s disease patients. J Alzheimers Dis 2015;46:93–107.
38Goodier MR, Jonjić S, Riley EM, Juranić Lisnić V: CMV and natural killer cells: shaping the response to vaccination. Eur J Immunol 2018;48:50–65.
39Collins A, Rothman N, Liu K, Reiner SL: Eomesodermin and T-bet mark developmentally distinct human natural killer cells. JCI Insight 2017;2:e90063.
40Stegmann KA, Robertson F, Hansi N, Gill U, Pallant C, Christophides T, Pallett LJ, Peppa D, Dunn C, Fusai G, Male V, Davidson BR, Kennedy P, Maini MK: CXCR6 marks a novel subset of T-bet(lo)Eomes(hi) natural killer cells residing in human liver. Sci Rep 2016;6:26157.
41Hudspeth K, Donadon M, Cimino M, Pontarini E, Tentorio P, Preti M, Hong M, Bertoletti A, Bicciato S, Invernizzi P, Lugli E, Torzilli G, Gershwin ME, Mavilio D: Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways. J Autoimmun 2016;66:40–50.
42van Helden MJ, de Graaf N, Boog CJ, Topham DJ, Zaiss DM, Sijts AJ: The bone marrow functions as the central site of proliferation for long-lived NK cells. J Immunol 2012;189:2333–2337.
43Blackman MA, Woodland DL: The narrowing of the CD8 T cell repertoire in old age. Curr Opin Immunol 2011;23:537–542.
44López-Botet M, Muntasell A, Martínez-Rodríguez JE, López-Montañés M, Costa-García M, Pupuleku A: Development of the adaptive NK cell response to human cytomegalovirus in the context of aging. Mech Ageing Dev 2016;158:23–26.
45Ljunggren HG, Kärre K: Experimental strategies and interpretations in the analysis of changes in MHC gene expression during tumour progression. Opposing influences of T cell and natural killer mediated resistance? J Immunogenet 1986;13:141–151.
46Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L: Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001;19:197–223.
47André P, Castriconi R, Espéli M, Anfossi N, Juarez T, Hue S, Conway H, Romagné F, Dondero A, Nanni M, Caillat-Zucman S, Raulet DH, Bottino C, Vivier E, Moretta A, Paul P: Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors. Eur J Immunol 2004;34:961–971.
48Krzewski K, Coligan JE: Human NK cell lytic granules and regulation of their exocytosis. Front Immunol 2012;3:335.
49Chavez-Galan L, Arenas-Del Angel MC, Zenteno E, Chavez R, Lascurain R: Cell death mechanisms induced by cytotoxic lymphocytes. Cell Mol Immunol 2009;6:15–25.
50Majewska-Szczepanik M, Paust S, von Andrian UH, Askenase PW, Szczepanik M: Natural killer cell-mediated contact sensitivity develops rapidly and depends on interferon-α, interferon-γ and interleukin-12. Immunology 2013;140:98–110.
51Farsakoglu Y, Palomino-Segura M, Latino I, Zanaga S, Chatziandreou N, Pizzagalli DU, Rinaldi A, Bolis M, Sallusto F, Stein JV, Gonzalez SF: Influenza vaccination induces NK-cell-mediated type-II IFN response that regulates humoral immunity in an IL-6-dependent manner. Cell Rep 2019;26:2307–2315.e5.
52Urlaub D, Höfer K, Müller ML, Watzl C: LFA-1 Activation in NK cells and their subsets: influence of receptors, maturation, and cytokine stimulation. J Immunol 2017;198:1944–1951.
53Burt BM, Plitas G, Stableford JA, Nguyen HM, Bamboat ZM, Pillarisetty VG, DeMatteo RP: CD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis. J Leukoc Biol 2008;84:1039–1046.
54Palgen JL, Tchitchek N, Elhmouzi-Younes J, Delandre S, Namet I, Rosenbaum P, Dereuddre-Bosquet N, Martinon F, Cosma A, Lévy Y, Le Grand R, Beignon AS: Prime and boost vaccination elicit a distinct innate myeloid cell immune response. Sci Rep 2018;8:3087.
55Pampena MB, Levy EM: Natural killer cells as helper cells in dendritic cell cancer vaccines. Front Immunol 2015;6:13.
56Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G: Reciprocal activating interaction between naturalkiller cells and dendritic cells. J Exp Med 2002;195:327–333.
57Amakata Y, Fujiyama Y, Andoh A, Hodohara K, Bamba T: Mechanism of NK cellactivation induced by coculture with dendritic cells derived from peripheral blood monocytes. Clin Exp Immunol 2001;124:214–222.
58Della